• SM-164: Bivalent Smac Mimetic Empowering Cancer Research Ass

  2026-06-10

  SM-164, a potent bivalent Smac mimetic from APExBIO, delivers rapid, reproducible apoptosis induction in diverse tumor models by targeting IAPs with sub-nanomolar affinity. Explore how optimized workflows and troubleshooting strategies with SM-164 drive reliable caspase activation and TNFα-dependent apoptosis, advancing cancer research beyond conventional approaches.

• Dextrose (D-glucose) Workflows for Tumor Immunometabolism

  2026-06-09

  Dextrose (D-glucose) is a cornerstone for dissecting glucose metabolism in hypoxic tumor microenvironments and immunometabolic research. This guide delivers actionable workflows, protocol enhancements, and troubleshooting strategies for maximizing data reliability in advanced cellular assays.

• NMDA Receptor-Driven Cav2.1 Channel Recruitment in PV Intern

  2026-06-09

  This study demonstrates that NMDA receptor signaling is crucial for the maturation of GABAergic synaptic transmission from neocortical parvalbumin (PV) interneurons, specifically through the recruitment of Cav2.1 channels. The findings clarify how developmental NMDAR hypofunction can disrupt inhibitory control, offering mechanistic insight relevant to neurodevelopmental disorders like schizophrenia.

• Sex Differences in Angiotensin II-Induced Hypertension in Mi

  2026-06-08

  Xue et al. provide mechanistic insight into how male and female mice respond differently to chronic angiotensin II-induced hypertension, using conscious telemetry and surgical hormone manipulation. Their findings highlight the protective role of female sex hormones and altered baroreflex regulation in males, advancing the field’s understanding of sex as a critical biological variable in cardiovascular research.

• MDL 28170 Calpain Inhibitor: Protocols for Neuroprotection

  2026-06-08

  MDL 28170 enables precise, translational workflows for neuroprotection and apoptosis assays by offering high selectivity for calpain and cathepsin B, rapid CNS accessibility, and proven efficacy in advanced in vivo and cell-based models. Its role in safeguarding neuronal structure and cognition—especially following ischemic or surgical insults—makes it a cornerstone for mechanistic and therapeutic studies across neuroscience and beyond.

• Tetramethylrhodamine Ethyl Ester Perchlorate in Mitochondria

  2026-06-07

  Tetramethylrhodamine ethyl ester perchlorate (TMRE) delivers unmatched sensitivity and quantitative insight for live-cell mitochondrial membrane potential assays. By leveraging TMRE’s robust fluorescence and low cytotoxicity, researchers can confidently dissect mitochondrial health, dysfunction, and bioenergetics in complex disease models—enabling translational discovery from mechanism to therapeutic evaluation.

• Bafilomycin C1 in Cardiotoxicity Screening: Beyond Autophagy

  2026-06-06

  Explore how Bafilomycin C1, a potent vacuolar H+-ATPases inhibitor, transforms cardiotoxicity screening in human iPSC-derived models. This article goes beyond standard autophagy assays to reveal new assay strategies and mechanistic insights, grounded in recent advances.

• Mitomycin C: Antitumor Antibiotic Solutions for Reliable Ass

  2026-06-05

  This article addresses real-world laboratory challenges in apoptosis signaling and cancer research, highlighting how Mitomycin C (SKU A4452) from APExBIO delivers reproducible, data-driven results. Through scenario-based analysis, it demonstrates the compound’s strengths in protocol optimization, data interpretation, and vendor reliability for cell viability and cytotoxicity workflows.

• UBE2F-SAG Neddylation of RHEB Drives mTORC1 Activation in Li

  2026-06-05

  This study identifies RHEB as a direct neddylation substrate of the UBE2F-SAG axis, revealing a mechanism that enhances mTORC1 activity and promotes liver tumorigenesis. The findings highlight the UBE2F-SAG-RHEB pathway as a potential therapeutic target in hepatocellular carcinoma and related metabolic diseases.

• Necrostatin 2: Optimizing Necroptosis Inhibition Workflows

  2026-06-04

  Necrostatin 2 (Nec-2) empowers researchers to dissect necroptosis with nanomolar precision, targeting the RIPK2 pathway even when apoptosis is blocked. This guide unpacks experimental strategies, troubleshooting, and actionable insights for advancing programmed necrotic cell death research.

• Stability-Driven mRNA Assays: EZ Cap™ Firefly Luciferase mRN

  2026-06-04

  Discover how EZ Cap™ Firefly Luciferase mRNA with Cap 1 structure empowers stability-focused research, bridging in vitro and in vivo performance. Uncover novel assay strategies and protocol optimizations that set this mRNA apart from existing bioluminescent reporter tools.

• Ceftolozane/Tazobactam: Innovations in Treating Resistant Gr

  2026-06-03

  The reference study provides a comprehensive evaluation of ceftolozane/tazobactam, a novel cephalosporin/β-lactamase inhibitor that addresses multidrug-resistant Gram-negative infections. Its unique pharmacodynamics and spectrum, especially against Pseudomonas aeruginosa and ESBL-producing Enterobacteriaceae, mark significant progress in combating antimicrobial resistance in clinical settings.

• Ademetionine’s Methylation Pathways in Neurological Disorder

  2026-06-03

  This review analyzes the central role of ademetionine (S-adenosylmethionine, SAMe) in CNS methylation and its clinical potential for neurological disorders. The findings highlight SAMe's broad metabolic functions, its interplay with folate and vitamin B12, and implications for neuropsychiatric treatment strategies.

• Pulchinenoside B4 Inhibits NLRP3 Inflammasome in Colitis via

  2026-06-02

  This study identifies Pulchinenoside B4 as a potent suppressor of NLRP3 inflammasome activation in macrophages, mediated by targeting CD1d and dampening the AKT-STAT1-PRDX1-NF-κB axis. The findings highlight a selective anti-inflammatory mechanism with translational potential for ulcerative colitis and provide a molecular framework for future inflammation research.

• TSPAN18 Stabilizes STIM1 to Drive Bone Metastasis in Prostat

  2026-06-02

  Zhou et al. uncover a novel mechanism where TSPAN18 protects STIM1 from TRIM32-mediated ubiquitination, promoting calcium signaling and bone metastasis in prostate cancer. These findings highlight TSPAN18 as a promising target for disrupting metastatic progression in hormone-responsive cancer research.

449 records 15/30 page Previous Next First page 上5页 1112131415 下5页 Last page